back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-05 11:41 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-63,700 vol |
0 | |
| Filed 2024-06-05 11:41 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-574,100 vol |
0 | |
| Filed 2024-06-05 11:40 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-251,097
-11,957 vol $21.00 each |
0 | |
| Filed 2024-01-05 12:15 Tx date 2023-08-31 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+11,957 vol |
11,957 | |
| Filed 2024-01-05 12:14 Tx date 2021-11-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 12:12 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
56 - Grant of rights
|
+63,700 vol |
63,700 | |
| Filed 2024-01-05 12:12 Tx date 2021-11-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-05 12:12 Tx date 2024-01-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+106,100 vol |
574,100 | |
| Filed 2023-01-09 09:08 Tx date 2023-01-05 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
468,000 | |
| Filed 2021-11-02 13:37 Tx date 2021-11-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+218,000 vol |
218,000 | |
| Filed 2021-11-02 13:36 Tx date 2021-11-01 |
$FUSN
Fusion Pharmaceuticals Inc. |
Leamon, Christopher Paul
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|